Medical tourism company Vaidam Health acquires MediJourney in an all-cash deal

Indian medical tourism platform Vaidam Health has acquired MediJourney, a digital-first international patient facilitation startup incubated by Ferns N Petals (FNP) in 2024. The deal, an all-cash transaction, marks a significant consolidation in India’s burgeoning cross-border healthcare ecosystem.

MediJourney, launched last year, enables international patients to connect with verified hospitals and treatment providers using a tech-enabled matchmaking interface. The acquisition will allow Vaidam Health to integrate MediJourney’s proprietary digital infrastructure into its platform, advancing its capabilities in patient onboarding, AI-assisted navigation, and multilingual case coordination.

“We welcome MediJourney to Vaidam Health,” said Pankaj Chandna, Co-Founder of Vaidam Health. “MediJourney’s platform complements our infrastructure and broadens our ability to connect international patients with trusted healthcare options in India. This acquisition reflects our commitment to simplifying access to quality treatment for patients worldwide.”

Founded in 2016 by Chandna and Manish Chandra, Vaidam Health facilitates over 25,000 monthly patient interactions and has an operational footprint spanning seven countries. The company provides a suite of services for medical travelers—including treatment discovery, visa facilitation, interpreter support, and post-care engagement—with a strong network of partner hospitals across India.

MediJourney will continue to operate independently under Vaidam’s ownership, with its core team focusing on new strategic opportunities. 

Rishabh Jalan, Co-Founder of MediJourney, said, “This acquisition represents a powerful synergy between two companies that share a common vision for innovation and customer-centric solutions. By joining forces with Vaidam Health, we are ensuring that our technology and expertise reach new heights, benefiting a wider audience while allowing us to focus on new strategic opportunities.”

The acquisition is projected to result in a 40 to 50% increase in active patient engagements over the next year, supported by Vaidam’s existing presence in international markets. The company plans to double down on its in-country teams and information centers in Africa and Southeast Asia to meet rising demand.